English | Español
Patient Daily | Dec 1, 2025

PhRMA Senior Director on 340B abuse: 'If Congress is serious about lowering drug costs, they must reform 340B'
Patient Daily | Dec 1, 2025

Six companies continue work on cell therapy despite recent industry exits
Patient Daily | Dec 1, 2025

New hereditary angioedema treatments expand options but patient switching remains limited
Patient Daily | Dec 1, 2025

Health organizations urge annual flu shots amid high-severity season
Patient Daily | Dec 1, 2025

Early introduction linked with sharp drop in childhood peanut allergies
Patient Daily | Dec 1, 2025

International team launches effort to speed up advances in follicular lymphoma research
Patient Daily | Nov 30, 2025

Researchers call for expanded monitoring after finding global spread of hidden antibiotic-resistant genes
Patient Daily | Nov 30, 2025

Regional conflicts worsen global surge in cholera amid rising climate threats

Trending
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Novavax shareholder plans to oppose CEO pay and board at upcoming meeting
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Kailera Therapeutics announces potential $533 million IPO in obesity drug market
+ Regulatory
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’